$89 Million is the total value of Summit Rock Advisors, LP's 3 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 80.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACWI | Buy | ISHARES TRmsci acwi etf | $49,567,000 | -9.9% | 792,180 | +14.1% | 55.68% | +23.1% |
| IUSV | Sell | ISHARES TRcore s&p us vlu | $23,531,000 | -59.3% | 509,549 | -44.5% | 26.44% | -44.4% |
| IEMG | New | ISHARES INCcore msci emkt | $15,916,000 | – | 393,289 | +100.0% | 17.88% | – |
| EB | Exit | EVENTBRITE INC | $0 | – | -18,282 | -100.0% | -0.30% | – |
| TLT | Exit | ISHARES TR20 yr tr bd etf | $0 | – | -29,868 | -100.0% | -3.33% | – |
| VOO | Exit | VANGUARD INDEX FDS | $0 | – | -14,600 | -100.0% | -3.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-04
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 29 | Q3 2020 | 90.6% |
| ISHARES TR | 26 | Q4 2020 | 51.7% |
| ISHARES INC | 11 | Q1 2020 | 64.0% |
| ISHARES TR | 11 | Q4 2021 | 47.6% |
| ISHARES TR | 9 | Q2 2015 | 34.5% |
| PHATHOM PHARMACEUTICALS INC | 9 | Q2 2022 | 1.1% |
| ISHARES TR RUS 2000 VAL ETF | 7 | Q4 2022 | 47.0% |
| SELECT SECTOR SPDR TR ENERGY | 6 | Q3 2023 | 67.4% |
| VANGUARD INTL EQUITY INDEX F | 5 | Q3 2022 | 45.3% |
| VANGUARD INDEX FDS | 4 | Q4 2021 | 36.4% |
View Summit Rock Advisors, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-26 |
| 13F-HR | 2023-10-24 |
| 13F-HR | 2023-07-21 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-01-12 |
| 13F-HR | 2022-11-02 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-10-26 |
View Summit Rock Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.